zonisamide has been researched along with Headache in 5 studies
Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.
Headache: The symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACHE DISORDERS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "At this moment, zonisamide represents a robust option in the treatment of a large number of patients with epilepsy, based on its multiple mechanism of action and efficacy in different situations." | 8.89 | [Zonisamide in the epilepsy treatment: a literature review from add-on therapy to monotherapy]. ( Serrano-Castro, PJ; Villanueva, V, 2013) |
| "Generally, prognosis of hypertensive encephalopathy in childhood is favorable." | 5.33 | Zonisamide eradicated paroxysmal headache with EEG abnormalities triggered by hypertensive encephalopathy due to purpura nephritic syndrome. ( Anzai, Y; Hayashi, M; Ohya, T, 2006) |
| "At this moment, zonisamide represents a robust option in the treatment of a large number of patients with epilepsy, based on its multiple mechanism of action and efficacy in different situations." | 4.89 | [Zonisamide in the epilepsy treatment: a literature review from add-on therapy to monotherapy]. ( Serrano-Castro, PJ; Villanueva, V, 2013) |
| "One hundred and twenty migraineurs who were refractory to topiramate were recruited." | 2.79 | Efficacy of zonisamide in migraineurs with nonresponse to topiramate. ( Chung, JY; Kim, M; Kim, MW, 2014) |
| " The most common adverse events were somnolence, headache, dizziness, and nausea during the titration phase and headache and pharyngitis during the fixed-dose assessment phase." | 2.71 | Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures. ( Bitenskyy, V; Brodie, MJ; Duncan, R; Lucas, C; Solyom, A; Vespignani, H, 2005) |
| "Generally, prognosis of hypertensive encephalopathy in childhood is favorable." | 1.33 | Zonisamide eradicated paroxysmal headache with EEG abnormalities triggered by hypertensive encephalopathy due to purpura nephritic syndrome. ( Anzai, Y; Hayashi, M; Ohya, T, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Villanueva, V | 1 |
| Serrano-Castro, PJ | 1 |
| Chung, JY | 1 |
| Kim, MW | 1 |
| Kim, M | 1 |
| Frediani, F | 1 |
| Brodie, MJ | 1 |
| Duncan, R | 1 |
| Vespignani, H | 1 |
| Solyom, A | 1 |
| Bitenskyy, V | 1 |
| Lucas, C | 1 |
| Anzai, Y | 1 |
| Hayashi, M | 1 |
| Ohya, T | 1 |
2 reviews available for zonisamide and Headache
| Article | Year |
|---|---|
[Zonisamide in the epilepsy treatment: a literature review from add-on therapy to monotherapy].
Topics: Adult; Animals; Anorexia; Anticonvulsants; Antioxidants; Carbonic Anhydrase Inhibitors; Child; Dizzi | 2013 |
Anticonvulsant drugs in primary headaches prophylaxis.
Topics: Amines; Anticonvulsants; Carbamazepine; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Fruct | 2004 |
2 trials available for zonisamide and Headache
| Article | Year |
|---|---|
Efficacy of zonisamide in migraineurs with nonresponse to topiramate.
Topics: Adult; Female; Fructose; Headache; Humans; Isoxazoles; Male; Middle Aged; Migraine Disorders; Parest | 2014 |
Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures.
Topics: Adolescent; Adult; Age Factors; Aged; Anticonvulsants; Child; Dose-Response Relationship, Drug; Doub | 2005 |
1 other study available for zonisamide and Headache
| Article | Year |
|---|---|
Zonisamide eradicated paroxysmal headache with EEG abnormalities triggered by hypertensive encephalopathy due to purpura nephritic syndrome.
Topics: Anticonvulsants; Child, Preschool; Electroencephalography; Female; Headache; Humans; Hypertensive En | 2006 |